Literature DB >> 20700569

[Pathophysiology and biochemistry of platelets].

K Jurk1, B E Kehrel.   

Abstract

Although their central role is to control bleeding and to induce thrombosis, platelets are important inflammatory and immune cells as well as modulators of angiogenesis. This review focuses on the different roles of platelets in hemostasis, thrombosis, inflammation, arteriosclerosis, angiogenesis, antimicrobial host defense and hematogenous tumor metastasis. Platelets are the central regulators of hemostasis. On their surface the important thrombin burst takes place. Platelets cause atherothrombotic vascular occlusions. However, they are probably involved in early stages of arteriosclerosis, e.g. extravasation of leukocytes at sites of vascular injury, formation of foam cells and proliferation of smooth muscle cells. These processes are triggered by secretion of proinflammatory substances and growth factors as well as by platelet-cell interactions via specific adhesive axes. During infections platelets kill pathogens through secretion of antimicrobial substances and extracellular traps or nets. Platelets facilitate the revascularisation of ischemic tissue and therefore even promote tumor growth.

Entities:  

Mesh:

Year:  2010        PMID: 20700569     DOI: 10.1007/s00108-010-2595-4

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  27 in total

1.  Soluble fibrin is the main mediator of Staphylococcus aureus adhesion to platelets.

Authors:  Silke Niemann; Nicola Spehr; Hugo Van Aken; Eberhard Morgenstern; Georg Peters; Mathias Herrmann; Beate E Kehrel
Journal:  Circulation       Date:  2004-06-14       Impact factor: 29.690

Review 2.  The tail of integrins, talin, and kindlins.

Authors:  Markus Moser; Kyle R Legate; Roy Zent; Reinhard Fässler
Journal:  Science       Date:  2009-05-15       Impact factor: 47.728

3.  Activated monocytes capture platelets for heterotypic association in patients with severe carotid artery stenosis.

Authors:  Kerstin Jurk; Martin A Ritter; Carsten Schriek; Hugo Van Aken; Dirk W Droste; E Bernd Ringelstein; Beate E Kehrel
Journal:  Thromb Haemost       Date:  2010-03-29       Impact factor: 5.249

4.  Candida albicans and its metabolite gliotoxin inhibit platelet function via interaction with thiols.

Authors:  Anne Bertling; Silke Niemann; Andreas Uekötter; Wolfgang Fegeler; Cornelia Lass-Flörl; Christof von Eiff; Beate E Kehrel
Journal:  Thromb Haemost       Date:  2010-04-29       Impact factor: 5.249

5.  Novel integrin-dependent platelet malfunction in siblings with leukocyte adhesion deficiency-III (LAD-III) caused by a point mutation in FERMT3.

Authors:  Kerstin Jurk; Ansgar S Schulz; Beate E Kehrel; Daniel Räpple; Harald Schulze; Dieter Möbest; Wilhelm W Friedrich; Heymut Omran; Erika Deak; Reinhard Henschler; Jürgen S Scheele; Barbara Zieger
Journal:  Thromb Haemost       Date:  2010-03-09       Impact factor: 5.249

Review 6.  High-density lipoproteins, platelets and the pathogenesis of atherosclerosis.

Authors:  Jerzy-Roch Nofer; Martin F Brodde; Beate E Kehrel
Journal:  Clin Exp Pharmacol Physiol       Date:  2010-03-12       Impact factor: 2.557

7.  Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization.

Authors:  Alexander Brill; Olga Dashevsky; Julia Rivo; Yaacov Gozal; David Varon
Journal:  Cardiovasc Res       Date:  2005-07-01       Impact factor: 10.787

8.  Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.

Authors:  P Clezardin; J Drouin; M C Morel-Kopp; M Hanss; B Kehrel; C M Serre; C Kaplan; P D Delmas
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

9.  P-selectin- and heparanase-dependent antimetastatic activity of non-anticoagulant heparins.

Authors:  Nina Hostettler; Annamaria Naggi; Giangiacomo Torri; Riva Ishai-Michaeli; Benito Casu; Israel Vlodavsky; Lubor Borsig
Journal:  FASEB J       Date:  2007-06-08       Impact factor: 5.191

Review 10.  Antimetastatic activities of modified heparins: selectin inhibition by heparin attenuates metastasis.

Authors:  Lubor Borsig
Journal:  Semin Thromb Hemost       Date:  2007-07       Impact factor: 4.180

View more
  1 in total

1.  State of the art in platelet function testing.

Authors:  Beate E Kehrel; Martin F Brodde
Journal:  Transfus Med Hemother       Date:  2013-03-18       Impact factor: 3.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.